Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor PCC

被引：0
|
作者：
Zahir, Hamim [1 ]
Vandell, Alexander [2 ]
Desai, Madhuri [1 ]
Maa, Jen-Fu [3 ]
Dishy, Victor [4 ]
Lomelli, Barbara [5 ]
Feussner, Annette [6 ]
Feng, Wenquin [7 ]
He, Ling [8 ]
Grosso, Michael A. [9 ]
Lanz, Hans J. [9 ]
Brown, Karen S. [1 ]
机构：
[1] Daiichi Sankyo Pharma Dev, Translat Med & Clin Pharmacol, Edison, NJ USA
[2] Daiichi Sankyo Pharma Dev, Clin Pharmacogen, Edison, NJ USA
[3] Daiichi Sankyo Inc, Biostat, Parsippany, NJ USA
[4] Daiichi Sankyo Pharma Dev, Expt Med, Edison, NJ USA
[5] Quintiles Inc, Early Clin Dev, Overland, KS USA
[6] CSL Behring GmbH, Preclin Rsch & Dev, Marburg, Germany
[7] Daiichi Sankyo Pharma Dev, Clin Biomarker Anal, Edison, NJ USA
[8] Daiichi Sankyo Pharma Dev, Clin Bioanal, Edison, NJ USA
[9] Daiichi Sankyo Pharma Dev, Clin Dev, Edison, NJ USA
来源：
CIRCULATION | 2014年 / 130卷 / 23期
关键词：
Anticoagulants; Factor xa; Dose-response relation; drug; Anticoagulation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2116 / 2116
页数：1
相关论文
共 50 条
  • [1] Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate
    Zahir, Hamim
    Brown, Karen S.
    Vandell, Alexander G.
    Desai, Madhuri
    Maa, Jen-Fue
    Dishy, Victor
    Lomeli, Barbara
    Feussner, Annette
    Feng, Wenqin
    He, Ling
    Grosso, Michael A.
    Lanz, Hans J.
    Antman, Elliott M.
    CIRCULATION, 2015, 131 (01) : 82 - +
  • [2] Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate (vol 131, pg 82, 2015)
    Zahir, Hamim
    CIRCULATION, 2015, 131 (01) : E10 - E10
  • [3] 4-FACTOR PCC DOSING FOR URGENT ANTICOAGULATION REVERSAL IN PATIENTS WITH OBESITY
    Etter, Elaina
    Lindsey, Lindsey
    Curry, Marjorie
    Morrison, Christopher
    Chester, Katleen
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 316 - 316
  • [4] EVALUATION OF 4-FACTOR PCC FOR HEMOSTASIS AND COAGULOPATHY REVERSAL IN NONANTICOAGULATED PATIENTS
    Jones, Savannah
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 309 - 309
  • [5] Low-dose 4-factor PCC for urgent warfarin reversal
    Zemrak, W.
    Smith, K.
    Rolfe, S.
    Hayes, T.
    Trowbridge, R.
    Seder, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 885 - 885
  • [6] ANDEXANET ALFA VERSUS 4-FACTOR PCC FOR REVERSAL OF INTRACRANIAL HEMORRHAGE ASSOCIATED WITH FACTOR XA
    Semon, Gregory
    Straughn, Angela
    Hardman, Claire
    Steel, Barbara
    Ekeh, Akpofure
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 301 - 301
  • [7] Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage
    Pasciolla, Stacy
    Wojcik, Kevin
    Kavi, Tapan
    Green, Danielle
    Shaikh, Hamza
    Jankowitz, Brian
    Igneri, Lauren A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (01) : 74 - 81
  • [8] EFFECT OF 4-FACTOR PCC REVERSAL PROTOCOL IN LVAD PATIENTS UNDERGOING HEART TRANSPLANTATION
    Wong, Man-Ching
    Mak, Hannah
    Ferreira, Renata
    CRITICAL CARE MEDICINE, 2019, 47
  • [9] Initial Experience with 4-Factor PCC for the Reversal of Warfarin: Patterns of Use and Safety Outcomes
    Morton, Colleen T.
    Dries, David J.
    Khan, Fatima
    BLOOD, 2014, 124 (21)
  • [10] Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage
    Stacy Pasciolla
    Kevin Wojcik
    Tapan Kavi
    Danielle Green
    Hamza Shaikh
    Brian Jankowitz
    Lauren A. Igneri
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 74 - 81
12345